Woman and Man
- | Country :
- Mexico
- | organs : -
- | Specialty : -
Extract
The purpose of this study is to determine if low-dose imatinib and nilotinib combination, will improve treatment results in CML patients with failure, suboptimal response or intolerance to imatinib therapy. The hypothesis is that with low-dose imatinib and nilotinib combination, major molecular response will be achieved in patients not previously obtained with imatinib monotherapy.
Inclusion criteria
- Leukemia, Myeloid, Chronic, BCR-ABL Positive